It has been reported that SYBU, a microtubule-associated protein, is overexpressed in hepatocellular carcinoma (HCC), which results in disrupted cell cycle and increased proliferation (Zheng and Yu, 2021). Here, SYBU is linked to hepatocellular carcinoma.